Bioorthogonal release of sulfonamides and mutually orthogonal liberation of two drugs

Chem Commun (Camb). 2018 Dec 13;54(100):14089-14092. doi: 10.1039/c8cc08533a.

Abstract

Sulfonamide derivatives have been used in pharmaceutics for decades. Here we report a new approach to release sulfonamides efficiently using a bioorthogonal reaction of sulfonyl sydnonimines and dibenzoazacyclooctyne (DIBAC). The second-order rate constant of the cycloaddition reaction can be up to 0.62 M-1 s-1, and the reactants are highly stable under physiological conditions. Most significantly, we also discovered the mutual orthogonality between the sydnonimine-DIBAC and benzonorbornadiene-tetrazine cycloaddition pairs, which can be used for selective and simultaneous liberation of sulfonamide and primary amine drugs.

MeSH terms

  • Azabicyclo Compounds / chemical synthesis
  • Azabicyclo Compounds / chemistry*
  • Celecoxib / chemical synthesis*
  • Celecoxib / chemistry
  • Click Chemistry
  • Cycloaddition Reaction
  • Cyclooxygenase 2 / chemistry
  • Cyclooxygenase Inhibitors / chemical synthesis
  • Cyclooxygenase Inhibitors / chemistry
  • Doxorubicin / chemical synthesis*
  • Enzyme Assays
  • Heterocyclic Compounds, 3-Ring / chemical synthesis
  • Heterocyclic Compounds, 3-Ring / chemistry*
  • Humans
  • Models, Chemical
  • Prodrugs / chemical synthesis
  • Prodrugs / chemistry*
  • Quantum Theory
  • Sydnones / chemical synthesis
  • Sydnones / chemistry*

Substances

  • Azabicyclo Compounds
  • Cyclooxygenase Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Prodrugs
  • Sydnones
  • Doxorubicin
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Celecoxib